2023 Q1 Form 10-Q Financial Statement

#000162828023001400 Filed on January 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4

Balance Sheet

Concept 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $818.0K $118.6M
YoY Change -75.57% 6805.36%
Cash & Equivalents $818.0K $864.0K
Short-Term Investments $0.00 $117.8M
Other Short-Term Assets $293.0K $288.0K
YoY Change 121.97% 44.72%
Inventory
Prepaid Expenses $198.0K $480.0K
Receivables $745.0K $238.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.226M $122.3M
YoY Change -45.66% 1834.02%
LONG-TERM ASSETS
Property, Plant & Equipment $2.769M $3.020M
YoY Change -7.45% 0.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.019M $920.0K
YoY Change 7.94% -2.54%
Total Long-Term Assets $7.555M $7.905M
YoY Change -94.29% -95.18%
TOTAL ASSETS
Total Short-Term Assets $4.226M $122.3M
Total Long-Term Assets $7.555M $7.905M
Total Assets $11.78M $130.3M
YoY Change -91.58% -23.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.55M $15.83M
YoY Change 72.03% 106.38%
Accrued Expenses $21.37M $19.34M
YoY Change 81.52% 109.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $39.54M $154.4M
YoY Change 74.34% 743.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.960M $8.043M
YoY Change -29.68% 62.42%
Total Long-Term Liabilities $7.960M $8.043M
YoY Change -29.68% 62.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $39.54M $154.4M
Total Long-Term Liabilities $7.960M $8.043M
Total Liabilities $47.50M $162.4M
YoY Change 39.71% 598.34%
SHAREHOLDERS EQUITY
Retained Earnings -$203.9M -$198.1M
YoY Change 22.17% 25.3%
Common Stock $6.000K $1.000K
YoY Change 100.0% -66.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$35.72M -$41.66M
YoY Change
Total Liabilities & Shareholders Equity $11.78M $130.3M
YoY Change -91.58% -23.55%

Cashflow Statement

Concept 2023 Q1 2022 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001675634
CY2022Q4 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
CY2022Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P0Y
CY2022Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2022Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
CY2022Q4 dei Document Type
DocumentType
10-Q
CY2022Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q4 dei Document Period End Date
DocumentPeriodEndDate
2022-11-30
CY2022Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q4 dei Entity File Number
EntityFileNumber
001-37954
CY2022Q4 dei Entity Registrant Name
EntityRegistrantName
SHIFTPIXY, INC.
CY2022Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2022Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4211438
CY2022Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
13450 W Sunrise Blvd
CY2022Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
CY2022Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Sunrise
CY2022Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33323
CY2022Q4 dei City Area Code
CityAreaCode
888
CY2022Q4 dei Local Phone Number
LocalPhoneNumber
798-9100
CY2022Q4 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2022Q4 dei Trading Symbol
TradingSymbol
PIXY
CY2022Q4 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q4 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q4 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9671196 shares
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
864000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
618000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
238000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
279000 usd
CY2022Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2706000 usd
CY2022Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2105000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
480000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
696000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
288000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
187000 usd
CY2022Q4 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
117770000 usd
CY2022Q3 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
116969000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
122346000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
120854000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3020000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2769000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3965000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4076000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
920000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
919000 usd
CY2022Q4 us-gaap Assets
Assets
130251000 usd
CY2022Q3 us-gaap Assets
Assets
128618000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
15827000 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
17122000 usd
CY2022Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
18766000 usd
CY2022Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
16055000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
575000 usd
CY2022Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
567000 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1438000 usd
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1362000 usd
CY2022Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
11500000 shares
CY2022Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
11500000 shares
CY2022Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
117770000 usd
CY2022Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
116969000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
154376000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
152075000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3453000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3541000 usd
CY2022Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
1196000 usd
CY2022Q3 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
1227000 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
3394000 usd
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
3269000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
162419000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
160112000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
151736000 usd
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8600000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8600000 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9671196 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
513349 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
156485000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-198148000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-192725000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-41662000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-40988000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
9494000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
9494000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-32168000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-31494000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
130251000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128618000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5266000 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8940000 usd
CY2022Q4 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
4845000 usd
CY2021Q4 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
8245000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
421000 usd
CY2021Q4 us-gaap Gross Profit
GrossProfit
695000 usd
CY2022Q4 us-gaap Salaries And Wages
SalariesAndWages
2259000 usd
CY2021Q4 us-gaap Salaries And Wages
SalariesAndWages
3890000 usd
CY2022Q4 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
10000 usd
CY2021Q4 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
27000 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
1195000 usd
CY2021Q4 us-gaap Professional Fees
ProfessionalFees
1737000 usd
CY2022Q4 pixy Software Development
SoftwareDevelopment
60000 usd
CY2021Q4 pixy Software Development
SoftwareDevelopment
1161000 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
149000 usd
CY2021Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
123000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1971000 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2340000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
5644000 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
9278000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-5223000 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-8583000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
0 usd
CY2021Q4 us-gaap Interest Expense
InterestExpense
1000 usd
CY2022Q4 us-gaap Other Income
OtherIncome
0 usd
CY2021Q4 us-gaap Other Income
OtherIncome
5000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5223000 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-8579000 usd
CY2022Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-200000 usd
CY2021Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-134000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-5423000 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-8713000 usd
CY2022Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
127145000 usd
CY2021Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-132568000 usd
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8713000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-13.88
CY2022Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-13.88
CY2021Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-24.00
CY2021Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-24.00
CY2022Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.02
CY2022Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.02
CY2021Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0
CY2021Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.90
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.90
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-24.00
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-24.00
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9533982 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9533982 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
359452 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
359452 shares
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-31494000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
127145000 usd
CY2022Q4 us-gaap Dividends Preferred Stock
DividendsPreferredStock
127145000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
255000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-5423000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-32168000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40920000 usd
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
408000 usd
CY2021Q4 pixy Remeasurement Of Temporary Equity
RemeasurementOfTemporaryEquity
13270000 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-8713000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30389000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-5423000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-8713000 usd
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-200000 usd
CY2021Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-134000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5223000 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-8579000 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
149000 usd
CY2021Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
123000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
255000 usd
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
408000 usd
CY2022Q4 pixy Warrant Modification Noncash Expense
WarrantModificationNoncashExpense
106000 usd
CY2021Q4 pixy Warrant Modification Noncash Expense
WarrantModificationNoncashExpense
0 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
23000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-41000 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-98000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
601000 usd
CY2021Q4 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-41000 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-115000 usd
CY2021Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
366000 usd
CY2022Q4 pixy Deposits Workers Compensation
DepositsWorkersCompensation
0 usd
CY2021Q4 pixy Deposits Workers Compensation
DepositsWorkersCompensation
200000 usd
CY2022Q4 pixy Increase Decrease In Deposits And Other Assets
IncreaseDecreaseInDepositsAndOtherAssets
-1000 usd
CY2021Q4 pixy Increase Decrease In Deposits And Other Assets
IncreaseDecreaseInDepositsAndOtherAssets
-73000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1295000 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1116000 usd
CY2022Q4 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2711000 usd
CY2021Q4 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
743000 usd
CY2022Q4 pixy Increase Decrease In Accrued Workers Compensation
IncreaseDecreaseInAccruedWorkersCompensation
-23000 usd
CY2021Q4 pixy Increase Decrease In Accrued Workers Compensation
IncreaseDecreaseInAccruedWorkersCompensation
-384000 usd
CY2022Q4 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1480000 usd
CY2021Q4 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1906000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3743000 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6673000 usd
CY2022Q4 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
1000 usd
CY2021Q4 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3742000 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6674000 usd
CY2022Q4 pixy Payments For Investment Of Initial Public Offering Proceeds
PaymentsForInvestmentOfInitialPublicOfferingProceeds
0 usd
CY2021Q4 pixy Payments For Investment Of Initial Public Offering Proceeds
PaymentsForInvestmentOfInitialPublicOfferingProceeds
116725000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
400000 usd
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
349000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-400000 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-117074000 usd
CY2022Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2021Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3502000 usd
CY2022Q4 pixy Proceeds From Variable Interest Entity Initial Public Offering
ProceedsFromVariableInterestEntityInitialPublicOffering
0 usd
CY2021Q4 pixy Proceeds From Variable Interest Entity Initial Public Offering
ProceedsFromVariableInterestEntityInitialPublicOffering
116725000 usd
CY2022Q4 pixy Proceeds From Warrant Exercises Net Of Offering Costs
ProceedsFromWarrantExercisesNetOfOfferingCosts
1000 usd
CY2021Q4 pixy Proceeds From Warrant Exercises Net Of Offering Costs
ProceedsFromWarrantExercisesNetOfOfferingCosts
0 usd
CY2022Q4 pixy Proceeds From Issuance Of Private Placement Net Of Offering Costs
ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
0 usd
CY2021Q4 pixy Proceeds From Issuance Of Private Placement Net Of Offering Costs
ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
4183000 usd
CY2022Q4 pixy Proceeds From Issuance Of Private Placement Prefunded Warrants Net Of Offering Costs
ProceedsFromIssuanceOfPrivatePlacementPrefundedWarrantsNetOfOfferingCosts
4387000 usd
CY2021Q4 pixy Proceeds From Issuance Of Private Placement Prefunded Warrants Net Of Offering Costs
ProceedsFromIssuanceOfPrivatePlacementPrefundedWarrantsNetOfOfferingCosts
6861000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4388000 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
124267000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
246000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
519000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
618000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1199000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
864000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1718000 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
1000 usd
CY2022Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2021Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q4 pixy Deferred Offering Costs Special Purpose Acquisition Companies
DeferredOfferingCostsSpecialPurposeAcquisitionCompanies
0 usd
CY2021Q4 pixy Deferred Offering Costs Special Purpose Acquisition Companies
DeferredOfferingCostsSpecialPurposeAcquisitionCompanies
9464000 usd
CY2022Q4 pixy Increase In Marketable Securities In Trust Account And Class A Mandatory Redeemable Common Shares
IncreaseInMarketableSecuritiesInTrustAccountAndClassAMandatoryRedeemableCommonShares
801000 usd
CY2021Q4 pixy Increase In Marketable Securities In Trust Account And Class A Mandatory Redeemable Common Shares
IncreaseInMarketableSecuritiesInTrustAccountAndClassAMandatoryRedeemableCommonShares
13270000 usd
CY2022Q4 pixy Transfer Of Preferred Shares To Common Shares
TransferOfPreferredSharesToCommonShares
1000 usd
CY2021Q4 pixy Transfer Of Preferred Shares To Common Shares
TransferOfPreferredSharesToCommonShares
usd
CY2022Q4 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumption as a going concern; management assumes that the Company will continue as a going concern , which contemplates continuity of operations, realization of assets and liquidation of all liabilities in the normal course of business;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Liability for legal contingencies;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Useful lives of property and equipment;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deferred income taxes and related valuation allowance;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Valuation of illiquid non-controlling interest in SPAC shares transferred; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Projected development of workers’ compensation claims.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions are difficult to measure of value. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Management regularly reviews the key factors and assumptions to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such valuation, if deemed appropriate, those estimates are adjusted accordingly.</span></div>
CY2022Q4 pixy Contract With Customer Term
ContractWithCustomerTerm
P12M
CY2022Q4 pixy Contract With Customer Cancellation Period
ContractWithCustomerCancellationPeriod
P30D
CY2022Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2706000 usd
CY2022Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2105000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5300000 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8900000 usd
CY2022Q4 pixy Gross Billings
GrossBillings
11700000 usd
CY2022Q4 pixy Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
10300000 usd
CY2021Q4 pixy Gross Billings
GrossBillings
14100000 usd
CY2021Q4 pixy Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
12300000 usd
CY2022Q4 pixy Workers Compensation Claim Responsibility Per Occurrence
WorkersCompensationClaimResponsibilityPerOccurrence
500000 usd
CY2020 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2022Q4 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit RiskThe Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal.
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
463000 usd
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
615000 usd
CY2022Q4 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
CY2022Q4 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
700000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2200000 usd
CY2022Q4 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
CY2021Q4 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
CY2022Q3 pixy Workers Compensation Asset Noncurrent
WorkersCompensationAssetNoncurrent
0 usd
CY2022Q3 pixy Workers Compensation Asset Current
WorkersCompensationAssetCurrent
0 usd
CY2022Q4 pixy Workers Compensation Asset Current
WorkersCompensationAssetCurrent
0 usd
CY2022Q4 pixy Workers Compensation Asset Noncurrent
WorkersCompensationAssetNoncurrent
0 usd
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
600000 usd
CY2022Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
600000 usd
CY2022Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
1200000 usd
CY2022Q3 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
1200000 usd
CY2022Q4 pixy Disposal Group Including Discontinued Operation Workers Compensation Liability Current
DisposalGroupIncludingDiscontinuedOperationWorkersCompensationLiabilityCurrent
1400000 usd
CY2022Q4 pixy Disposal Group Including Discontinued Operation Workers Compensation Liability Noncurrent
DisposalGroupIncludingDiscontinuedOperationWorkersCompensationLiabilityNoncurrent
3400000 usd
CY2022Q4 pixy Disposal Group Including Discontinued Operation Workers Compensation Asset Current
DisposalGroupIncludingDiscontinuedOperationWorkersCompensationAssetCurrent
0 usd
CY2022Q4 pixy Disposal Group Including Discontinued Operation Workers Compensation Asset Noncurrent
DisposalGroupIncludingDiscontinuedOperationWorkersCompensationAssetNoncurrent
0 usd
CY2022Q4 us-gaap Advertising Expense
AdvertisingExpense
700000 usd
CY2021Q4 us-gaap Advertising Expense
AdvertisingExpense
1400000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
4004000 usd
CY2021Q3 pixy Deferred Offering Costs Excluding Fees
DeferredOfferingCostsExcludingFees
47472000 usd
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1263351 shares
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
178941 shares
CY2022Q4 pixy Share Based Compensation Arrangement By Share Based Payment Award Number Of Stock Based Compensation Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfStockBasedCompensationPlans
1 plan
CY2022 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
4004000 usd
CY2021Q3 us-gaap Deferred Costs
DeferredCosts
48261000 usd
CY2021Q3 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
789000 usd
CY2021Q4 pixy Variable Interest Entity Qualitative Or Quantitative Information Common Stock Shares Transferred
VariableInterestEntityQualitativeOrQuantitativeInformationCommonStockSharesTransferred
15000 shares
CY2022Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
117800000 usd
CY2021Q4 pixy Remeasurement Of Temporary Equity
RemeasurementOfTemporaryEquity
13000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
4000000 usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2021Q2 pixy Other Commitments Number Of Special Purpose Acquisition Company Sponsorships
OtherCommitmentsNumberOfSpecialPurposeAcquisitionCompanySponsorships
4 sponsorship
CY2021Q2 pixy Other Commitments Capital Investment Sought Per Acquisition Company
OtherCommitmentsCapitalInvestmentSoughtPerAcquisitionCompany
150000000 usd
CY2022Q1 pixy Withdrawal From Spacs1 Forms
WithdrawalFromSPACS1Forms
38000000 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
116725000 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
116725000 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
900000 usd
CY2021Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000 usd
CY2021Q2 pixy Other Commitments Percentage Of Outstanding Shares Per Acquisition Company
OtherCommitmentsPercentageOfOutstandingSharesPerAcquisitionCompany
0.15
CY2021Q2 pixy Other Commitments Number Of Special Purpose Acquisition Company Sponsorships
OtherCommitmentsNumberOfSpecialPurposeAcquisitionCompanySponsorships
4 company
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
0 usd
CY2021Q4 pixy Remeasurement Of Temporary Equity
RemeasurementOfTemporaryEquity
13000000 usd
CY2022Q1 pixy Other Commitments Number Of Special Purpose Acquisition Company Sponsorships Withdrawn From
OtherCommitmentsNumberOfSpecialPurposeAcquisitionCompanySponsorshipsWithdrawnFrom
3 sponsorship
CY2022 pixy Deferred Offering Costs Increase Decrease
DeferredOfferingCostsIncreaseDecrease
38500000 usd
CY2022Q3 pixy Deferred Offering Costs Excluding Fees
DeferredOfferingCostsExcludingFees
38000000 usd
CY2022 pixy Expensed Spac Offering Costs
ExpensedSPACOfferingCosts
500000 usd
CY2022Q4 us-gaap Cash
Cash
900000 usd
CY2022Q4 pixy Working Capital Deficit
WorkingCapitalDeficit
32000000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3700000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-198100000 usd
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1 shares
CY2022Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
127145000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
522786 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P7Y2M12D
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
47.99
CY2022Q4 pixy Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
854166 shares
CY2022Q4 pixy Class Of Warrant Or Right Weighted Average Remaining Life Issued
ClassOfWarrantOrRightWeightedAverageRemainingLifeIssued
P7Y1M6D
CY2022Q4 pixy Class Of Warrant Or Right Weighted Average Exercise Price Issued
ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
12.00
CY2022Q4 pixy Class Of Warrant Or Right Shares Exercised
ClassOfWarrantOrRightSharesExercised
124204 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1252748 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P6Y10M24D
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
34.78
CY2022Q4 pixy Class Of Warrant Or Right Shares Exercisable
ClassOfWarrantOrRightSharesExercisable
50173 shares
CY2022Q4 pixy Weighted Remaining Life Years Exercisable
WeightedRemainingLifeYearsExercisable
P3Y
CY2022Q4 pixy Weighted Average Exercise Price Exercisable
WeightedAverageExercisePriceExercisable
459.36
CY2020Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
250000 shares
CY2020Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3000000 shares
CY2021Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3000000 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
255000 usd
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
408000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
11753 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11753 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
733.00
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
733.00
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2022Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2022Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1150 shares
CY2022Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
217.00
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10603 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10603 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y9M18D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
789.00
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
789.00
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1458000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5269 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1146
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
830 shares
CY2022Q4 pixy Weighted Average Remaining Contractual Life In Years Vested
WeightedAverageRemainingContractualLifeInYearsVested
P8Y
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
426.00
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
369 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
286.00
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5730 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y7M6D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1101
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
10603 shares
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
10603 shares
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
789.00
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
789.00
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5730 shares
CY2022Q4 pixy Share Based Payment Arrangement Option Exercise Price Range Vested Weighted Average Remaining Contractual Term
ShareBasedPaymentArrangementOptionExercisePriceRangeVestedWeightedAverageRemainingContractualTerm
P7Y7M6D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1101
CY2022Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
127145000 usd
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
3900000 usd
CY2022Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
3800000 usd
CY2022Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
3800000 usd
CY2022Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
256000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
919000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1064000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1099000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
777000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
568000 usd
CY2022Q4 pixy Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
351000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4778000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
621000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4157000 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P72M
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0554
CY2021Q2 pixy Other Commitments Number Of Special Purpose Acquisition Company Sponsorships
OtherCommitmentsNumberOfSpecialPurposeAcquisitionCompanySponsorships
4 sponsorship
CY2022Q4 pixy Other Commitments Outstanding Uncollectible Loans
OtherCommitmentsOutstandingUncollectibleLoans
744000 usd

Files In Submission

Name View Source Status
0001628280-23-001400-index-headers.html Edgar Link pending
0001628280-23-001400-index.html Edgar Link pending
0001628280-23-001400.txt Edgar Link pending
0001628280-23-001400-xbrl.zip Edgar Link pending
ex311_053122x10q.htm Edgar Link pending
ex312_053122x10q.htm Edgar Link pending
ex321_053122x10q.htm Edgar Link pending
ex322_053122x10q.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pixy-20221130.htm Edgar Link pending
pixy-20221130.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
pixy-20221130_def.xml Edgar Link unprocessable
pixy-20221130_lab.xml Edgar Link unprocessable
pixy-20221130_cal.xml Edgar Link unprocessable
pixy-20221130_pre.xml Edgar Link unprocessable
pixy-20221130_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable